Avidity Biosciences, Inc Capital Reinvestment Ratio
Avidity Biosciences, Inc capital reinvestment ratio. Avidity Biosciences, Inc (RNAM) has a Capital Reinvestment Ratio of 0.05x as of December 2023, meaning it reinvests 0% of its operating cash flow ($16.50 Million) in capital expenditures ($863.00K). See RNAM cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Avidity Biosciences, Inc (2019–2019)
Capital reinvestment ratio of Avidity Biosciences, Inc from 2019 to 2019. This chart tracks Avidity Biosciences, Inc's Capital Reinvestment Ratio across 1 annual periods. See RNAM FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Avidity Biosciences, Inc Capital Reinvestment Ratio by Year (2019–2019)
Avidity Biosciences, Inc capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see cash flow conversion of Avidity Biosciences, Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.09x | $2.49 Million | $235.00K | — |